Sustainability Report

Overview

The report describes Centrient Pharmaceuticals' 2017 sustainability strategy around reducing environmental impact, improving human health and social impact, and combating antimicrobial resistance. It reports 44% energy-consumption improvement against a 43% target for Type I sites, 83% of net sales from ECO+ products, and the opening of a new Delft fermenter for sustainable 7-ADCA. The company also reports 1,945 global employees at year-end and extensive employee, community, and wastewater-treatment programs.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2017
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services